Profile data is unavailable for this security.
About the company
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company dedicated to the advancement of identifying and translating novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology and orthopedics. The Company conducts substantially all of its commercial operations through its subsidiary, Creative Medical Technologies, Inc. Its products include AlloStem (CELZ-201-DDT) - allogenic human perinatal tissue derived cell program (clinical phase), ImmCelz (CELZ-100) - personalized supercharged immune therapy platform (pre-clinical trials), Type I Diabetes (CELZ-201 CREATE-1) - type I diabetes, Allostemspine Chronic Lower Back Pain (CELZ 201 ADAPT), Alova, CaverStem - erectile dysfunction treatment, FemCelz - female sexual function treatment, StemSpine - regenerative stem cell procedure for the treatment of degenerative disc disease (clinical trials), and OvaStem - stem cell therapy for premature ovarian failure.
- Revenue in USD (TTM)9.00k
- Net income in USD-5.28m
- Incorporated1998
- Employees4.00
- LocationCreative Medical Technology Holdings Inc211 E. Osborn Rd.PHOENIX 85012United StatesUSA
- Phone+1 (480) 399-2822
- Websitehttps://creativemedicaltechnology.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sonnet Biotherapeutics Holdings Inc | 92.74k | -8.43m | 5.73m | 12.00 | -- | 1.88 | -- | 61.75 | -5.28 | -5.28 | 0.0315 | 0.9813 | 0.0097 | -- | 0.2248 | 7,728.33 | -87.68 | -- | -194.11 | -- | -- | -- | -9,086.22 | -- | -- | -138.21 | 0.00 | -- | -57.76 | -- | 36.64 | -- | -- | -- |
Hoth Therapeutics Inc | 0.00 | -7.70m | 5.77m | 2.00 | -- | 0.6634 | -- | -- | -2.02 | -2.02 | 0.00 | 1.78 | 0.00 | -- | -- | 0.00 | -70.17 | -157.07 | -77.15 | -177.32 | -- | -- | -- | -- | -- | -50.67 | 0.00 | -- | -- | -- | 31.01 | -- | -- | -- |
HST Global Inc | 0.00 | -146.22k | 5.77m | 1.00 | -- | -- | -- | -- | -0.0279 | -0.0279 | 0.00 | -0.1128 | 0.00 | -- | -- | -- | -17,002.33 | -5,836.01 | -- | -- | -- | -- | -- | -- | -- | -26.54 | -- | -- | -- | -- | -0.7858 | -- | -- | -- |
NanoString Technologies Inc | 162.47m | -166.43m | 5.77m | 703.00 | -- | -- | -- | 0.0355 | -3.53 | -3.53 | 3.44 | -1.05 | 0.4936 | 2.07 | 4.30 | 231,113.80 | -50.56 | -30.01 | -62.82 | -34.66 | 35.72 | 57.14 | -102.44 | -80.87 | 2.02 | -70.17 | 1.29 | -- | -12.28 | 2.06 | -38.43 | -- | 40.03 | -- |
Burzynski Research Institute Inc | 0.00 | -1.19m | 5.78m | 2.00 | -- | -- | -- | -- | -0.009 | -0.009 | 0.00 | -0.0003 | 0.00 | -- | -- | -- | -84,895.00 | -10,098.54 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 6.18 | -- | -- | -- |
Titan Pharmaceuticals Inc | 185.00k | -5.57m | 5.80m | 4.00 | -- | 0.7461 | -- | 31.33 | -7.40 | -7.40 | 0.246 | 8.50 | 0.0305 | -- | 4.51 | 46,250.00 | -91.72 | -96.80 | -138.02 | -156.65 | -- | -- | -3,010.27 | -406.26 | 5.55 | -- | 0.07 | -- | -66.97 | -51.16 | 45.43 | -- | -65.61 | -- |
Synaptogenix Inc | 0.00 | -12.23m | 5.86m | 5.00 | -- | 0.2338 | -- | -- | -37.38 | -37.38 | 0.00 | 21.08 | 0.00 | -- | -- | 0.00 | -13.75 | -40.33 | -15.54 | -43.36 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -142.17 | -- | -3.21 | -- |
Healthy Extracts Inc | 2.49m | -2.47m | 5.93m | -- | -- | 6.19 | -- | 2.38 | -0.8588 | -0.8588 | 0.8611 | 0.3231 | 0.918 | 0.4921 | 36.50 | -- | -91.32 | -53.78 | -174.02 | -146.65 | 65.90 | 45.68 | -99.48 | -87.53 | 0.1636 | -9.72 | 0.5245 | -- | 10.41 | 105.93 | -151.54 | -- | -- | -- |
Palisade Bio Inc | 0.00 | -13.49m | 5.96m | 9.00 | -- | 0.5381 | -- | -- | -24.67 | -24.67 | 0.00 | 11.82 | 0.00 | -- | -- | 0.00 | -96.63 | -132.36 | -111.78 | -165.45 | -- | -- | -- | -27,892.32 | -- | -874.31 | 0.00 | -- | -- | -0.7814 | 13.74 | -- | 18.53 | -- |
Glucose Health Inc | 1.11m | -456.46k | 5.97m | 2.00 | -- | 6.30 | -- | 5.37 | -0.033 | -0.033 | 0.0803 | 0.0561 | -- | -- | -- | -- | -- | -86.94 | -- | -153.95 | 47.19 | 40.68 | -31.99 | -56.93 | 313.11 | -- | 0.00 | -- | 98.39 | 24.94 | 16.87 | -- | -- | -- |
Creative Medical Technology Holdings Inc | 9.00k | -5.28m | 6.04m | 4.00 | -- | 0.6532 | -- | 670.78 | -3.74 | -3.74 | 0.0064 | 6.81 | 0.0007 | 0.4291 | -- | 2,250.00 | -42.47 | -110.00 | -43.88 | -- | 60.00 | 65.82 | -58,624.33 | -7,961.14 | 23.53 | -- | 0.00 | -- | -89.84 | -40.86 | 47.88 | -- | -- | -- |
Shineco Inc | 4.50m | -13.99m | 6.16m | 87.00 | -- | 0.0158 | -- | 1.37 | -3.93 | -4.63 | 0.4431 | 60.93 | 0.0558 | 0.3932 | 0.9844 | 51,761.38 | -18.99 | -12.77 | -34.44 | -16.84 | 11.94 | 25.88 | -340.48 | -102.06 | 0.4903 | -9.04 | 0.3792 | -- | -- | -58.35 | -33.86 | -- | -- | -- |
Soligenix Inc | 839.36k | -6.14m | 6.20m | 13.00 | -- | 1.62 | -- | 7.39 | -0.9164 | -0.9164 | 0.1085 | 0.243 | 0.0697 | -- | 5.86 | 64,566.15 | -51.01 | -75.40 | -872.23 | -154.32 | 11.59 | 22.83 | -731.60 | -620.02 | -- | -1,677.11 | 0.5639 | -- | -11.54 | -30.67 | 55.50 | -- | -- | -- |
Cannabis Bioscience Internatnl Hlgs Inc | 56.94m | 6.94m | 6.23m | 389.00 | 0.0011 | 0.0001 | 0.6752 | 0.1094 | 0.5328 | 0.5328 | 4.29 | 4.92 | 0.5917 | 62.81 | 1.45 | 146,384.30 | 7.83 | -- | 11.73 | -- | 31.96 | -- | 13.24 | -- | 0.6856 | 50.75 | 0.0631 | -- | 12.79 | -- | 177.84 | -- | -- | -- |
Cell MedX Corp | 70.00 | -96.91k | 6.24m | 0.00 | -- | -- | -- | 89,170.91 | -0.0029 | -0.0029 | 0.00 | -0.0024 | 0.0015 | -- | -- | -- | -202.28 | -792.55 | -- | -- | -685.71 | -- | -138,442.90 | -3,681.84 | -- | -3.17 | -- | -- | -54.53 | -- | 29.01 | -- | -- | -- |
Holder | Shares | % Held |
---|---|---|
The Vanguard Group, Inc.as of 31 Mar 2024 | 17.63k | 1.30% |
Aaron Wealth Advisors LLCas of 31 Mar 2024 | 16.40k | 1.21% |
UBS Securities LLCas of 31 Dec 2023 | 1.04k | 0.08% |
Tower Research Capital LLCas of 31 Dec 2023 | 903.00 | 0.07% |
Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Dec 2023 | 20.00 | 0.00% |
Wells Fargo Bank, NA (Private Banking)as of 31 Mar 2024 | 11.00 | 0.00% |
IFP Advisors, Inc.as of 31 Dec 2023 | 5.00 | 0.00% |
Vanguard Advisers, Inc.as of 31 Mar 2024 | 3.00 | 0.00% |
Arbor Point Advisors LLCas of 31 Mar 2024 | 1.00 | 0.00% |
The O'Dell Group LLCas of 31 Mar 2024 | 0.00 | 0.00% |